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From life-threatening to chronic disease: Is this
the case of cancers? A systematic review
Silvia Francesca Maria Pizzoli1,2*, Chiara Renzi2, Paola Arnaboldi3, William Russell-Edu4 and
Gabriella Pravettoni1,2
Abstract: Problem identification: Given the importance of a common scientific back-
ground on what clinicians mean by the term chronic cancer (CC), the present review
examines whether and to what extent a shared definition of CC exists in the literature.
Literature Search: A systematic search of the existing literature dealing with the
definition of CC was performed.
Synthesis: Considering a statement of the American Cancer Society on CC, a list of
attributes for a cancer to be considered chronic was drawn up and used as a common
schema to evaluate and organize a description of CC provided by relevant articles.
Conclusions: Overall, most of the relevant articles recognized a time criterion as
a peculiar attribute of a CC, however, there is only a limited degree of overlap within
the literature definitions of CC.
Implication for Practice: It may be useful to talk about a chronic phase within
a broader cancer disease continuum.
Subjects: Social Sciences; Behavioral Sciences; Education
Keywords: chronic cancer; chronic disease; definition; cancer care; oncology
1. Introduction
In recent years, improvements in the identification of risk factors, earlier diagnosis and new
treatments have resulted in an increase of the number of cancer patients living longer; even in
the case of malignancies that cannot be cured, but can be controlled, current treatments enable
many patients to live for years after the diagnosis.
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The transformation of cancer from a rapidly and inevitably fatal disease into a condition that can
be managed over time, has led to the definition of cancer as a chronic disease (Schmidt, 2016;
Ward, Schiller, & Goodman, 2014; WHO, 2015).
This kind of transition is not unique in the history of medicine; analogous cases could be
described for kidney failure, chronic respiratory diseases, chronic cardiovascular diseases, diabetes
and even AIDS/HIV, which like some cancers, cannot be cured, but can be controlled for extended
periods of time.
Such transitions did not merely imply a change in the linguistic definition, but rather a pivotal
shift in many aspects: from communication, to care flow models, to the role of the patients and
their family systems, up to health-care policies. The shift to chronic illness, in fact, raises issues
about patient empowerment and patient self-management (Bodenheimer, Wagner, & Grumbach,
2002; Boerger-Knowles & Tashi, 2015; Harley, 2012) and using the label “chronic” itself may shape
the attitudes of doctors, patients and caregivers.
Within a chronicity framework, patients with a chronic cancer (CC) should, in fact, be considered
as experts in their own condition, becoming their principal caregiver (Leventhal, Leventhal, &
Breland, 2011; Wagner, 1998).
But, can cancer nowadays be considered a chronic illness?
Firstly, we should note that persons receiving a diagnosis of cancer, or patients at their first line
treatments may believe that healing is the primary objective of care; conversely, a person diag-
nosed with diabetes or asthma, knows from the very moment of the diagnosis that the illness is
a chronic one. A cancer may be stable, as abnormal proliferation and replication may be stopped,
or may be progressive, as it continues to develop, whereby although the cancer cells cannot be
interrupted, symptoms control is still possible. These aspects profoundly affect patient-physician
communication and the cognitive aspects of coping with the illness (Gorini & Pravettoni, 2011).
From the oncologist’s point of view, even though clinicians already claim many advanced
cancers as chronic diseases, there are as yet no international guidelines for the support of patients
living with (chronic) cancers. Albeit worthy of attention, CC seems to be poorly defined and there
seems to be no unified agreement on when the chronic phase begins or ends. The need for a better
definition of cancer as a (chronic) disease is increasingly becoming recognized (Berlinger & Flamm,
2009; Berlinger & Gusmano, 2011; Harley, Pini, Bartlett, & Velikova, 2012), especially when it comes
to devising interventions in the field of healthcare.
How do physicians categorize and recognize a CC patient? What features should CC present?
One of the major challenges in defining cancer as a chronic disease is the lack of unified criteria
for an illness to be considered as “chronic” (Goodman, Posner, Huang, Parekh, & Koh, 2013). The
term “chronic” itself resides between the category of cured and the category of terminal, encom-
passing many different and heterogeneous situations.
According to the World Health Organization (WHO, 2011) which lists cancers as one of the four
main types of chronic illnesses, chronic diseases are diseases of long duration and generally slow
progression, without any specification about functional limitation and need for ongoing medical
treatments and care, conversely to the aforementioned definition. However, in the case of cancers,
one must also take into consideration the potential need for ongoing medical treatment, signifi-
cant impairment, and reduction in quality of life.
The US Department of Health & Human Services states that chronic diseases are “condi-
tions that last a year or more and require ongoing medical treatment and/or limit activities of
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daily living.”. (Goodman et al., 2013) Certainly, some advanced cancers, such as chronic
myelogenous leukaemia (CML) (Pulte, Redaniel, Bird, & Jeffreys, 2015) meet the criteria in
terms of duration, the need for ongoing medical treatment and functional impairment.
However, a 12-month criterion for a disease to be chronic is possibly not applicable to the
field of cancer care. This is first because in the case of some malignancies the situation may
unpredictably worsen within time, and secondly because, as mentioned previously, patients
diagnosed with cancer, unlike patients with other well-known chronic conditions, may believe
that a cure is possible.
A description provided by the American Cancer Society (2013) lists some features of CC, char-
acterizing it as an advanced cancer that can be managed for months or even for years, that can
become stable using treatments or enter a repeating cycle of remission and recurrence.
Even if such a definition offers some important boundaries for identifying what a CC should “look
like”, several particular aspects of cancer still render its shift into a “chronic condition” problematic
(Tritter, 2002).
Cancer is a cellular categorization, rather than a singular entity or disease, and it encompasses
a broad range of illnesses. This means that it is very hard to provide a list of unique features for
a “template” of cancer to be considered chronic, since there are many diseases/cancers (lung,
breast, ovarian, bowel, etc.), and many different illnesses affecting the same localization (e.g.,
mesothelioma, small cell lung cancer, etc.). Each disease has different incidences, mortality rates
and may require treatments that differ markedly. Furthermore, the predictability of treatments
and prognosis even in the light of the same microscopic characteristics is rather low compared to
other chronic diseases (Hebdon, Foli, & Mccomb, 2015; Tritter, 2002).
We dare say that patients’ common-sense definition and that of oncologists differ markedly so
that a potentially insidious misunderstanding occurs. For example, after a recurrence of an ovarian
cancer, the oncologist may tell the patient that no more curative intent is available and that they
will try to “chronicize” the cancer. Patients usually understand that they are to live with ovarian
cancer from that point on, as would be the case with a diabetes diagnosis. However, the median
overall survival after the first, second, third, fourth and fifth ovarian cancer relapse (Hanker et al.,
2012) is very different from that associated with diabetes or asthma.
Given the importance of a definition for the health-care flow and for the patients’ mindset, to
shed light on the definition of chronic cancer(s), papers dealing with the concept of cancer as
a chronic illness were systematically reviewed to find out whether and to what extent a shared
definition of cancer as a chronic disease can be found in the literature.
2. Methods
2.1. Selection procedures and data collection
2.1.1. Search strategy
A comprehensive literature search was designed and conducted by an experienced medical
librarian (WRE) with input from the study investigators. We searched the electronic databases
Ovid MEDLINE, Embase, Scopus, Pubmed and ProQuest Psychology. Various combinations of
database-specific controlled vocabulary (subject headings) were used, supplemented by key-
words, title and abstract terms for the concepts and synonyms relating to chronic cancer and
its definition. Bibliographies of relevant papers were examined and citing articles were
identified using ISI Web of Science. English language restrictions were applied, and the
date restriction was from 1980 onwards. The full search strategies employed are reported
in the Table A1.
Pizzoli et al., Cogent Psychology (2019), 6: 1577593
https://doi.org/10.1080/23311908.2019.1577593
Page 3 of 17
2.1.2. Inclusion criteria
Articles included for the systematic review dealt with the concept of CC as they (a) clearly
attempted to give a general definition of CC, (b) stated that some specific cancers must
be defined or considered as chronic diseases, (c) considered some clinical issues
regarding cancer patients within a framework of chronicity, giving some specific attributes
or definition of CC.
All the included articles were written in English and dealt with human cancers.
The search results are summarized in the (Prisma) Flow Chart in Figure 1.
2.1.3. Exclusion criteria
Articles excluded from the review were: (i) duplicates, (ii) articles that did not provide any definition
or description of what they considered as CC or of which attributes are related to CC.
2.1.4. Included studies
A total of 510 studies were identified through the initial search strategy from databases, 451 were
removed by after examining the title and abstract.
A total of 40 were excluded as they did not provide an explicit definition or specific criteria to
explain or characterize cancer as a chronic illness.
S
c
r
e
e
n
in
g
In
c
lu
d
e
d
 
E
li
g
ib
il
it
y
 
Id
e
n
t
if
ic
a
t
io
n
 
Records screened 
(n = 510) 
Records excluded 
(n = 451) 
Full-text articles assessed 
for eligibility 
(n = 59)
Full-text articles excluded 
(n = 40) 
Studies included  
(n = 28) 
EMBASE 
(n = 45) 
ProQuest 
Psychology 
(n = 7)
Ovid 
Medline 
(n = 304)
PubMed 
(n = 130) 
Studies from reference list 
of relevant articles 
(n = 9)
Scopus 
(n = 24) 
Figure 1. Flow Chart of the stu-
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A total of 19 of the studies identified through the initial search were included in the review and 9
additional studies that met the inclusion criteria were found through a manual search of the
bibliography of the initial relevant studies. In all, 28 articles were included in the present review.
3. Results
3.1. Study characteristics
Overall, 28 studies were included in the present review.
Among the included articles, there are four reviews, one concept analysis, 17 editorials, com-
mentaries, special issues or theoretical articles, four cross-sectional or longitudinal studies on
cancer patients, and two case studies.
Overall, two studies explicitly attempted to define CC, while there were nine articles stating that
some specific cancer types may be considered as chronic illnesses. Sixteen articles listed cancer or
some specific cancer types as chronic disease, giving a detailed description of what or why they
considered cancers disease to be chronic.
3.2. CC features
Overall, each one of the included articles provided some attributes or criteria for CC.
Considering the American Cancer Society (2013) regarding CC, a list of characteristics of CCs was
drawn up. Definitions or descriptions of the features of CC provided by relevant articles were
organized according to those specific features.
The first key feature we identified from the American Cancer Society statement (2013) was (i)
cancer stage (advanced or metastatic); the second referred to the possibility of healing or not (ii)
curative intent; the third related to the fact that existing treatments may allow for symptom
control, rendering CC manageable (iii) symptom control and the fourth dealt with the presence
of (iv) cycle of remission and recurrence. The last category refers to the time dimension and to the
possibility of a long-term survivorship (v) estimated survival.
Descriptions of relevant articles were organised according to those key features in Table 1, to
highlight which characteristics were represented the most in the literature and to assess whether
and to what extent some shared characteristics of what is considered CC can be determined in the
literature. Studies’ characteristics and the extent to which they overlap with the definition provided
by the American Cancer Society (on a scale from 1 to 5 point, representing the key features
aforementioned) are reported in Table 2.
Overall, 23 articles recognized time criterion (estimated survival) as a CC characteristic, while 10
identified the presence of cycle remission and recurrence in CCs. There were nine articles which
listed symptom control and seven mentioned cancer stage as relevant aspects of CC, while five
articles addressed the curative intent dimension of CC.
3.3. General CC definitions
In 1953, Morton and Morton summarized clinical cases with cancers behaving as chronic diseases,
showing that chronicity was not related to a specific cancer type (1953).
Within a chronic disease framework, Dorsett (1991) analyses the trajectory of cancer recovery,
considering cancer a chronic disease characterized by episodic and acute morbidities, with the
possibility of more prolonged remission compared to the past.
During an anthropological analysis on chronic illnesses, Heurtin-Roberts and Becker (1993)
include cancer as a chronic condition and define chronic illnesses as health conditions that can
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Table 2. Studies’ description and the extent to which they provide definition features over-
lapping with the American Cancer Society
Study Objective/Topic Article type Sample Definition
Armstrong, 2002 Review and discuss
long term
management issues
in cancer patients
Brief review and Case
Study
One case ●○○○○
Berlinger & Flamm,
2009
Discuss effectiveness
in the field of CC
Opinion - ●●●●○
Berlinger & Gusmano,
2011
Policy challenges in
CC
Perspective - ●●○○○
Bernell, Howard, &
Paterson, 2016
Define chronic
diseases
Opinion - ●●○○○
Bodai & Tuso, 2015 Issues and
recommendation in
breast cancer
survivorship
Review - ●○○○○
Boerger-knowles &
Tashi, 2015
Explore theoretical
perspectives for
counselling patients
with CC
Perspective Case reports ●●●●○
D’Angio, 2007 Discuss if childhood
cancer can be
considered a chronic
disease
Perspective - ●○○○○
DePue, 2008 Hematologic cancer
considered as
a chronic disease
Symposium - ●○○○○
Dorsett, 1991 Give a theoretical
framework for the
trajectory of cancer
recovery
Perspective - ●○○○○
Doyle-Lindrud, 2007 Describe the evolution
of prostate cancer
Case Study One case ●○○○○
Frick et al., 2017 Analyse treatment-
related effects and
need of cancer
survivors
Original Article 5847 cancer survivors ●●●●○
Gosain & Miller 2013 Overview of the
natural history of
cancer survivorship
Review article Two case studies ●●●○○
Guttilla, Bortolami, &
Evangelista, 2015
Analyse the course of
prostate cancer
Review article - ●○○○○
Harley et al., 2012 Define chronic cancer Original Article 56 patients with
advanced cancer
●●●●○
Hebdon, Foli, &
Mccomb, 2015
Define cancer survivor Concept Analysis Case reports ●○○○○
Heurtin-Roberts &
Becker, 1993
Give an
anthropological
perspective on
chronic diseases
Perspective - ●●○○○
Kagawa-Singer, 1993 Define a broad
concept of health
Original article 50 cancer patients ●○○○○
Lage & Crombet,
2011
Analyse the course of
chronic cancer
Review - ●●○○○
Markman & Malviya,
2008
Describe recurrence
and remission of
ovarian cancer
Case Study 1 patient ●○○○○
(Continued)
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be managed over time, but not cured, and that have periodic or ongoing symptoms. Authors
referred in particular to the Kagawa-Singer paper, (1993) that examines how a sample of cancer
patients, viewed as chronic patients, can live with a particular state of health, unlike health
definitions commonly used in health-care settings. The majority of the sample is composed of
breast cancer and colorectal cancer patients; the remaining patients had cancers of various sites.
ForWalker (2001) according to the improvement of cancer survival rate, some cancers, such as those of
the cervix, prostate and oesophagus, are more probably to be included among chronic diseases, than
among terminal ones. Possible distinguishing features of chronicity, according to the author, may be
duration, the insidious and incurable nature of the disease and its periodic, episodic or recurrent nature
(2001).
In a commentary on childhood cancer, D’Angio (2007)wrote that somemalignant entities that typically
have a prolonged course,might be labelled as chronic in a proper way, thus referring the “chronicity” label
to diseases with favourable survival rates. The author lists mesenchymal chondrosarcoma and alveolar
soft part sarcoma as examples of malignant entities that might well be termed as chronic.
According to Berlinger and Flamm (2009) CC can be used to address advanced cancers, that
cannot be cured, but can be stable or be stabilized with treatments, or cancers with cycles of
recurrence, remission and treatment that can prevent cancer.
Naus, Ishler, Parrott and Kovacs (2009) placed cancer survivorship within a chronicity frame-
work, focusing on the need for a long term adjustment for cancer patients.
In a review concerning the shift of cancer from a rapidly fatal disease to a chronic condition,
Lage and Crombet (2011) trace lines of evidence of a transition of advanced cancers to chronicity
in the improvement of long term survival rates (2011). According to Phillips and Currow (2010)
living as a cancer survivor means living with a chronic recurrent or ongoing condition.
Study Objective/Topic Article type Sample Definition
Markman, 2006 Discuss the meaning
of considering ovarian
cancer as a chronic
disease
Editorial - ●●○○○
McCorkle et al., 2011 Chronic patient
empowerment
Review - ●●○○○
Morton & Morton,
1953
Describe cases with
chronic cancer
Case reports 17 case studies ●●○○○
Naus, Ishler, Parrot, &
Kovacs, 2009
Model of cancer as
a chronic disease
Perspective - ●○○○○
Phillips & Currow,
2010
Overview Perspective - ●○○○○
Polinsky, 1994 Demonstrate chronic
nature of cancer
Original Article 223 cancer patients ●○○○○
Reed & Corner, 2015 Explore the illness
trajectory of
metastatic breast
cancer
Original Article 10 cancer patients ●●○○○
Sutton, 2016 Debate on skin cancer
as a chronic disease
Commentary - ●●○○○
Walker, 2001 Definitions and needs
related to chronic
illnesses
Perspective - ●○○○○
Abbreviation: CC (chronic cancer)
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According to Berlinger and Gusmano (2011) some incurable but treatable cancers, could potentially
be considered as CCs and be managed as chronic conditions by the patient’s self-management as his
or her own principal caregiver. CML is recognized by the authors as a disease that fits easily into
a category of chronic disease (2011).
McCorkle et al. (2011) analysing self-management needs of patients living with cancer as
a chronic condition, state that, as patients are living longer, cancer may be managed as
a chronic illness occurring on a continuum that runs from prevention to end of life.
Harley et al. (2012) built up a “working definition” of CC, identifying boundaries to establish when
the chronic phase of cancer begins or ends in selected breast, renal, colorectal, gynaecological and
prostate cancer patients.
The principal point listed by Harley et al. (2012) relates to the fact that CC is a cancer that cannot
be cured, but it is active, advanced or metastatic and can be managed with treatments that lead
to slow disease progression, symptom control and prolonged life. When patients are likely to have
only months of survival and no treatments still exist, the chronic phase ends (2012).
Gosain and Miller (2013) in a review on symptom management in long-term cancer survivors,
described a phase of chronic cancer survivorship as a phase in which patients live with a CC that
may be either on an ongoing remission or active but controlled.
In a 2015 concept analysis on survivor in cancer context Hebdon, Foli and McComb (2015),
highlight that the most descriptive term in the context of cancer is “malignancy”, a category that
includes carcinoma, sarcoma, leukaemia, lymphoma and central nervous system cancers. The
authors also discussed the variability within cancer patients (Hebdon et al., 2015), who have
different personal experiences within the cancer care flow continuum, needing individualized care.
Boerger-knowles and Tashi (2015) focusing on the fact that living with CC often causes func-
tional and relational changes, explicitly reported the American Cancer Society (American Cancer
Society, 2013) definition in the introduction of their manuscript, stating what they considered to be
CC. Authors also described cases with recurrence and remission.
According to Sutton (2016), non-melanoma skin cancer can be considered chronic diseases in
a specific subgroup of patients, as it meets the US Department of Health & Human Services
definition of chronic disease (Goodman et al., 2013) by reason of its prolongation, need for ongoing
medical care and for the functional damage it causes.
Frick et al. (2017) identify the category of CC survivors in those patients living with a metastatic
or recurrent cancer or new diagnosis of a second cancer, as well as those who had a diagnosis of
chronic lymphocytic leukaemia (CLL) or CML, at least at two years from their diagnosis. The
greatest percentage of CC survivors identified is composed of breast cancer patients (2017).
3.4. Specific CC definitions
Breast, ovarian and prostate cancer have been identified as chronic cancers by several authors.
According to Polinsky (1994), long-term breast cancer survivors (from 16 months to
32 years from their original surgery) live a chronic illness characterized by lifelong follow
up medical care.
Reed and Corner (2015) explore the illness trajectory of metastatic breast cancer patients, that
ranged from 13 months to 5 years and 9 months, concluding that metastatic breast cancer is
increasingly becoming of a chronic nature. A 2015 comprehensive review dealing with breast
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cancer survivorship (Bodai & Tuso, 2015) assesses long term medical and lifestyle issues, consider-
ing breast cancer as a CC because it leads to long term survivorship.
For ovarian cancer, the median survival range of 12 to 24months of patients with recurrent ovarian
cancer is said by Armstrong (2002) to demonstrate that the disease has a “chronic natural history”.
In a 2006 editorial, Markman (2006) stated that ovarian cancer can be considered a CC, due to
the fact that for a significant percentage of ovarian cancer patients the disease can recur, and the
patient becomes a prolonged survivor whose life expectancy may be measurable in years and for
whom cure is not a plausible aim (2006).
In a subsequent case study, Markman and Malviya (2008) report the 11-year survival of
a woman with recurrent advanced epithelial ovarian cancer, underlining that it can be considered
chronic in nature.
Finally, as regards prostate cancer, Doyle-Lindrud (Doyle-Lindrud, 2007) concludes that prostate
cancer possesses a chronic nature that needs extensive medical management. Guttilla, Bortolami,
and Evangelista (2015) summarized and evaluated cost-effectiveness and follow-up of prostate
cancer as a chronic disease, stating that this oncological condition can be considered chronic,
because of its long median survival (42 months).
Hematologic cancer has also been considered as a chronic condition. According to DePue (2008),
many hematologic cancers (i.e. multiple myeloma) are now perceived as chronic conditions, as
a result of multiple therapies that allow a longer survival.
4. Discussion
Even though there appears to be no unique and common definition of chronic cancer emerging from
the relevant published medical literature, a certain degree of overlap can be observed between the
attributes of CC and with the description given by the American Cancer Society (2013).
It is not surprising that only certain CC features are reported and discussed by the selected articles,
as the aim of most the papers was not to provide an explicit and complete definition of what CC is.
Overall, most of the articles recognized a time criterion for a CC definition, i.e. the estimated
survival, and almost all the articles that identify a specific cancer type as a CC, made use of a time
criterion. In a longitudinal perspective, beginning with cancer diagnosis itself, it seems that the
term “chronic” fits well with the recognition of a specific phase in the cancer trajectory more than
as an attribute of the cancer itself.
According to selected articles, the time course for a cancer to be considered chronic ranged from
months to years of survival, with the end of the chronic phase being placed when the patient, as
referred to by Harley et al. (2012) had only months to live. Although the majority of the articles
identified “time to live” as a basic criterion for CC, no common start and endpoint emerged and, as
Harley and colleagues noted, the lack of a shared definition of when the chronic cancer phase should
begin or end, poses some difficulties in defining what is a CC in a unique way (2012). Thus, it emerges
from the literature that cancer can be defined as “chronic” on the basis of the characteristics of some
of its phases and not as a chronic illness itself such as asthma or diabetes. Noteworthy, as it is difficult
for oncologists to predict cancer time course and knowing disease duration a priori, it is hard to
establish when the chronic care phase should begin for the specific patient.
Furthermore, as mentioned in the introduction, a 12-month criterion for a disease to be chronic
may not be appropriate in the field of cancer care, as in the first treatment year, many particular
difficulties may arise.
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The initial diagnosis of cancer often requires a substantial and immediate treatment (e.g., in the
case of liquid tumours), in contrast to the typical responses to a chronic disease (Bell & Ristovski-
Slijepcevic, 2013); in addition, a tumour may respond unpredictably to treatment and may display
a significant capacity to change (Berlinger & Flamm, 2009).
Cancer is still associated with mortality by newly-diagnosed patients (Tritter, 2002). Few other
chronic illness diagnoses raise such strong concerns about death, rendering the diagnosis of
cancer a very stressful event, both for the patients and their family.
Finally, considering the model of chronic illness trajectories (Wellard, 1998), there are other huge
differences between cancer and other chronic illnesses. Register (1987) described chronic illness as
involving a first adjustment phase defined as “legitimization of symptoms”: this is not the case for
cancer patients for whom the initial psychological burden is that of processing the socially recognized
life-threatening nature of diagnosis and of nurturing hope regarding the possibility of being cured.
The presence of cycles of remission and recurrence and the possibility of controlling symptoms
were reported by almost one-third of relevant articles. Existing treatment options that allow for
cancer stabilization and its cyclic nature were considered as salient attributes of CC.
Thus, according to studies emerging from the medical literature, cancer as a chronic disease is
something that can be medically controlled and managed for a certain time extent or that can
present a recurrent form.
Importantly, only certain cancer types may be included in these criteria, as most cancers, unlike
other chronic illnesses, can become resistant to the treatment and adapt themselves (Berlinger &
Flamm, 2009), with a capacity to change that is the norm rather than the exception (2009).
In terms of cancer stage and the goal of treatment, a minority of authors explicitly described CC as
advanced or metastatic and as a disease that cannot be cured. Such criteria have been explored in
more depth by certain authors probably as a result of the heterogeneity of cancer types considered in
relevant articles. The heterogeneity of different cancer types (stage, site, type of cancer) is reflected
also by the fact that most authors recognized different cancer forms as template or examples of CC.
According to some authors, certain specific cancer types fit better with the model of CC: breast,
ovarian and hematologic cancers were those most identified (Armstrong, 2002; Berlinger & Flamm,
2009; Berlinger & Gusmano, 2011; Bodai & Tuso, 2015; DePue, 2008; Frick et al., 2017; Markman,
2006; Markman & Malviya, 2008; Polinsky, 1994; Pulte et al., 2015; Reed & Corner, 2015).
Because the definition of CC given by the American Cancer Society (2013) encompasses a broad
and heterogeneous population of patients, distinct patient groups, for instance, those with differ-
ent cancer sites or those with metastatic cancers versus locally recurrent cancers, should be
studied separately (Frick et al., 2017).
When it comes to authoritative definitions, it is worth noting that authors took into consideration
patients suffering from chronic cancer who received diagnosis at least from a 12 to 16 month
period (Armstrong, 2002; Harley et al., 2012; Polinsky, 1994; Reed & Corner, 2015), meeting the
duration criterion listed by the US Department of Health and Human Services. Aspects related to
functional limitations as well as to the need for ongoing medical treatment were also addressed or
considered to some extent by a relevant number of papers (Berlinger & Flamm, 2009; Berlinger &
Gusmano, 2011; Bodai & Tuso, 2015; Boerger-Knowles & Tashi, 2015; D’Angio, 2007; Dorsett, 1991;
Frick et al., 2017; Guttilla et al., 2015; Harley et al., 2012; Hebdon et al., 2015; Lage & Crombet,
2011; Markman, 2006; Markman & Malviya, 2008; McCorkle et al., 2011; Reed & Corner, 2015;
Sutton, 2016), showing that, at least to some degree, the US Department definition of a chronic
disease was reflected in the literature.
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Overall, in terms of seeking clarity amongst the range of possible definitions, the following
general and interrelated issues seem to be resolved or to have been taken into consideration in
building a shared concept of what comprises CC.
There is a significant variability within different cancer types, given by the fact that “cancer” is an
umbrella term for uncontrolled cellular replication, identifying a group of illnesses, rather than
a unique condition (Hebdon et al., 2015; Tritter, 2002): different cancers may behave in very
different ways throughout time, and different sites and stages define different populations of
patients (Frick et al., 2017). The American Cancer Society’s definition itself encompasses different
cancer types, such as ovarian cancer, chronic leukaemias, and some lymphomas, as well as
metastatic breast or prostate cancer (2013).
There are also chronic changes associated with therapies: cancers may modify themselves with
unpredictable cellular proliferation (Berlinger & Flamm, 2009; Berlinger & Gusmano, 2011), leading
to a random growth and to unstable responses to therapies. Furthermore, cycle of recurrence and
remission may take place. Acute episodes may occur many times, rendering it difficult to apply
a consistent label to cancer as “chronic”.
In the cancer trajectory, there are some chronic and some acute phases, therefore, it is not
possible to talk about cancer as a chronic disease in its entirety, rather it is possible to identify
a chronic phase in cancer course. Furthermore, acute episodes that usually occur during the
“chronic” phase, leading to a repetition of acute and chronic phases, provoke a continuous shift
in the patient’s self-perception of his/her illness (Tritter, 2002).
Moreover, the features associated with CC, are very broad characteristics, with ambiguous
boundaries. It is difficult to define a long-term survivorship or to define in a unique way the fact
that a cancer may be controlled but not cured or to what extent symptoms are truly controlled.
Another point worthy of emphasis centres on the impact of using the adjective “chronic” in cancer
care considering the patient–health-care provider relationship and communication issues: very often,
cancer patients in their 50s and 60s are also affected by some other chronic conditions such as
cardiovascular disease or diabetes. If their cancer recurs or is advanced at diagnosis, when they hear
their oncologists talk also about their cancer as a chronic condition, a misunderstanding is created
because they overlap the model of chronicity that pertains to diabetes with that which pertains to
cancer. It is well-known that cancer treatments exert amore profound impact on quality of life than do
treatments for other chronic conditions.
Finally, it is hard to establish which features of CC are necessary and sufficient for a cancer to be
defined as chronic, since all the aspects listed in the medical literature are characteristics that a CC
may possess, and not the characteristics that a CC must possess. This further serves to render the
CC label susceptible to a certain vagueness and confusion.
5. Conclusions
To some extent, the features associated with the concept of CC in the literature overlap with one
another and with the American Cancer Society (2013) statements on chronic tumours. There is
also a certain degree of overlap between official definitions of a chronic disease (US Department of
Health and Human Services, 2010; WHO, 2015) and the attributes of CC.
5.1. Implications for psychosocial oncology
The relevant heterogeneity within the definition of CC and the issues highlighted in the literature
deserve attention. The label “chronic” should be used with caution. Indeed, besides the attributes
and definitional issues pertaining to specific cancers, it is worthy of note that many authors also
discuss the problematic issues in the transition of cancer into a chronic condition.
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The scientific community should explore whether it makes sense to talk about the presence of
a cancer phase with chronic characteristics rather than talk about cancer as a chronic condition
itself. Including the model of chronicity in cancer care implies implementing and delivering specific
training modules in communications skills to health-care professionals (Arnaboldi & Pravettoni,
2016) to face the issue of survival with long-lasting and demanding therapies, impaired quality of
life and a non-defined temporal horizon.
When patients enter the “no longer curative phase”, oncologists have an important issue to over-
come. With the number of drugs at their disposal that could improve survival for months and some-
times even years, they have to deal with the hope for cure of their patients. It is the case of patients
whom they follow for months, even years and with whom a therapeutic relationship is always started.
It happens that oncologists start speaking to their patients of the main treatment purpose being “to
chronicize” their illness. In the mind of patients, hearing the term “chronic” as applied to cancer
activates some cognitive maps that relate cancer to the course of other chronic illnesses such as
diabetes and asthma. On the other hand, evidence from the literature affirms that the number of
deaths following the cancers mentioned above did not decline regardless of the prevalence. This
becomes a communication bias that creates a cognitive dissonance in the patient’s mind: patients feel
reassured being told their cancer could be chronic (like diabetes and asthma) but they are also scared
because they are confronted on a daily basis with people dying from the very same condition with
which they are affected. This is a heavily demanding task for the teammembers who in themajority of
cases have followed their patients for years along multiple chemotherapy regimens and life hopes. In
some cases, the utilization of “chronic” as an adjective in cancer care may be more the result of an
affective predisposition aimed at sharing hope rather than the result of a medical evidence. However,
given the severity of cancer, there is a greater importance now ever before that CC patients receive the
close attention they deserve, focusing on personal experiences and building personalized patterns of
care aimed at the true empowerment of patients (Bailo, Guiddi, Vergani, Marton, & Pravettoni, 2019).
5.2. Key messages
● There is a relevant heterogeneity within the definition of CC employed in literature
● As cancers’ shift into a chronicity framework presents several issues, the label “chronic” should
be used with caution
● The scientific community should explore whether it makes sense to talk about the presence of
a cancer phase with chronic characteristics rather than talk about cancer as a chronic condi-
tion itself
Funding
The authors received no direct funding for this research.
Author details
Silvia Francesca Maria Pizzoli1,2
E-mail: silviafrancescamaria.pizzoli@ieo.it
Chiara Renzi2
E-mail: chiara.renzi01@gmail.com
Paola Arnaboldi3
E-mail: paola.arnaboldi@eoc.ch
William Russell-Edu4
E-mail: william.russell-edu@ieo.it
Gabriella Pravettoni1,2
E-mail: gabriella.pravettoni@ieo.it
1 Department of Oncology and Hemato-Oncology,
University of Milan, Via Festa del Perdono 7, Milan
20141, Italy.
2 Applied Research Division for Cognitive and Psychological
Science, European Institute of Oncology, IRCCS, Milan,
20141, Italy.
3 Service of Psychiatry and Psychological Medicine (SPPM),
Cantonal Socio-psychiatric Organization, Lugano Savosa,
Switzerland.
4 Library, European Institute of Oncology, IRCCS, Milan,
20141, Italy.
Disclosure Statement
Authors have declared no conflict of interests.
Citation information
Cite this article as: From life-threatening to chronic dis-
ease: Is this the case of cancers? A systematic review,
Silvia Francesca Maria Pizzoli, Chiara Renzi, Paola
Arnaboldi, William Russell-Edu & Gabriella Pravettoni,
Cogent Psychology (2019), 6: 1577593.
References
American Cancer Society. (2013). Managing Cancer as
a Chronic Illness. Retrieved from https://www.can
cer.org/treatment/survivorship-during-and-after-
treatment/when-cancer-doesnt-go-away.html
Armstrong, D. K. (2002). Relapsed ovarian cancer:
Challenges and management strategies for
a chronic disease. Oncologist, 7 Supp 5
(Supplement5), 20–28. doi:10.1634/
THEONCOLOGIST.7-SUPPL_5-20
Arnaboldi, P., & Pravettoni, G. (2016). How and to what
extent can the humanities support oncology per-
sonnel? Could we devise a formula to guide
policymakers? Journal of Cancer Policy, 8, 7–8.
doi:10.1016/j.jcpo.2016.03.001
Pizzoli et al., Cogent Psychology (2019), 6: 1577593
https://doi.org/10.1080/23311908.2019.1577593
Page 14 of 17
Bailo, L., Guiddi, P., Vergani, L., Marton, G., & Pravettoni, G.
(2019). The patient perspective: Investigating patient
empowerment enablers and barriers within the onco-
logical care process. Ecancermedicalscience. In Print.
Bell, K., & Ristovski-Slijepcevic, S. (2013). Cancer survivor-
ship: Why labels matter. Journal of Clinical Oncology :
Official Journal of the American Society of Clinical
Oncology, 31(4), 409–411. doi:10.1200/
JCO.2012.43.5891
Berlinger, N., & Flamm, A. L. (2009). Define “effective” the
curious case of chronic cancer. The Hastings Center
Report, 39(6), 17–20. Retrieved from http://www.ncbi.
nlm.nih.gov/pubmed/20050366
Berlinger, N., & Gusmano, M. (2011). Cancer chronicity:
New research and policy challenges. Journal of
Health Services Research & Policy, 16(2), 121–123.
doi:10.1258/jhsrp.2010.010126
Bodai, B. I., & Tuso, P. (2015). Breast cancer survivorship:
A comprehensive review of long-term medical issues
and lifestyle recommendations. The Permanente
Journal, 19(2), 48–79. doi:10.7812/TPP/14-241
Bodenheimer, T., Wagner, E. H., & Grumbach, K. (2002).
Improving primary care for patients. JAMA, 288(15),
1909–1914.
Boerger-Knowles, K., & Tashi, R. (2015). Chronic Cancer:
Counseling the individual. Social Work in Health Care,
53(1), 11–30. doi:10.1080/00981389.2013.840355
D’Angio, G. J. (2007). Is childhood cancer a chronic
disease? Journal of Pediatric Hematology/Oncology,
29(9), 595–597. doi:10.1097/
MPH.0b013e3181462307
DePue, R. J. (2008). Managed care considerations:
Hematologic cancer as a chronic disease. Managed
Care (Langhorne, Pa.), 17(7), preceding table of con-
tents. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/19119536
Dorsett, D. S. (1991). The trajectory of cancer recovery.
Scholarly Inquiry for Nursing Practice, 5, 3.
Doyle-Lindrud, S. (2007). Prostate cancer: A chronic
illness. Clinical Journal of Oncology Nursing, 11(6),
857–861. doi:10.1188/07.CJON.857-861
Frick, M. A., Vachani, C. C., Bach, C., Hampshire, M. K.,
Arnold-Korzeniowski, K., Metz, J. M., & Hill-Kayser,
C. E. (2017, June). Survivorship and the chronic can-
cer patient: Patterns in treatment-related effects,
follow-up care, and use of survivorship care plans.
Cancer, 123, 4268–4276. doi:10.1002/cncr.30862
Goodman, R. A., Posner, S. F., Huang, E. S., Parekh, A. K., &
Koh, H. K. (2013). Defining and measuring chronic
conditions: Imperatives for research, policy, program,
and practice. Preventing Chronic Disease, 10, 120239.
doi:10.5888/pcd10.120239
Gorini, A., & Pravettoni, G. (2011). An overview on cogni-
tive aspects implicated in medical decisions.
European Journal of Internal Medicine, 22(6),
547–553. doi:10.1016/j.ejim.2011.06.008
Gosain, R., & Miller, K. (2013). Symptoms and symptom
management in long-term cancer survivors. Cancer
Journal (Sudbury, Mass.), 19(5), 405–409.
doi:10.1097/01.PPO.0000434391.11187.c3
Guttilla, A., Bortolami, A., & Evangelista, L. (2015). Prostate
cancer as a chronic disease: Cost-effectiveness and
proper follow-up. Quarterly Journal of Nuclear Medicine
and Molecular Imaging, 59(4), 439–445.
Hanker, L. C., Loibl, S., Burchardi, N., Pfisterer, J., Meier, W.,
Pujade-Lauraine, E., … Du Bois, A. (2012). The impact
of second to sixth line therapy on survival of relapsed
ovarian cancer after primary taxane/platinum-based
therapy. Annals of Oncology : Official Journal of the
European Society for Medical Oncology / ESMO, 23
(10), 2605–2612. doi:10.1093/annonc/mds203
Harley, C. (2012, April). Defining chronic cancer : Patient
experiences and self-management needs. BMJ
Supportive Palliative Care, 2(3), 248–255. doi:10.1136/
bmjspcare-2012-000200
Harley, C., Pini, S., Bartlett, Y. K., & Velikova, G. (2012).
Defining chronic cancer : Patient experiences and
self-management needs. BMJ Supportive & Palliative
Care, 2(April 2017), 248–255. doi:10.1136/bmjspcare-
2012-000200
Hebdon, M., Foli, K., & Mccomb, S. (2015, January).
Survivor in the cancer context : A concept analysis.
Journal of Advanced Nursing, 71, 1774–1786.
doi:10.1111/jan.12646
Heurtin-Roberts, S., & Becker, G. (1993). Anthropological
chronic perspectives illness. Social Science & Medicine,
37(3), 281–283. doi:10.1016/0277-9536(93)90259-7
Kagawa-Singer, M. (1993). Redefining health : Living with
cancer. Social Science & Medicine, 37(3), 295–304.
doi:10.1016/0277-9536(93)90261-2
Lage, A., & Crombet, T. (2011). Control of advanced can-
cer : The road to chronicity. 683–697. doi:10.3390/
ijerph8030683
Leventhal, H., Leventhal, E., & Breland, J. (2011). Cognitive
science speaks to the “common sense” of chronic
illness management. Annals of Behavioral Medicine :
a Publication of the Society of Behavioral Medicine, 41,
152–163. doi:10.1007/s12160-010-9246-9
Markman, M. (2006). Viewing ovarian cancer as a “chronic
disease”: What exactly does this mean? Gynecologic
Oncology, 100(2), 229–230. doi:10.1016/j.
ygyno.2005.08.043
Markman, M., & Malviya, V. (2008). An example of ovarian
cancer as a “chronic disease process” - A 11-Year
survival with multiple treatments for recurrent and
progressive disease. Case Reports in Oncology, 1, 1–4.
doi:10.1159/000164683
McCorkle, R., Ercolano, E., Lazenby, M., Schulman-Green,
D., Schilling, L. S., Lorig, K., & Wagner, E. H. (2011).
Self-management: Enabling and empowering
patients living with cancer as a chronic illness. CA:
a Cancer Journal for Clinicians, 61(1), 50–62.
doi:10.3322/caac.20093.Available
Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, & Group, The
PRISMA. (2009). Preferred reporting items for sys-
tematic reviews and meta-analyses: the prisma
statement. Plos Med, 6(7), e1000097. doi: 10.1371/
journal.pmed1000097
Morton, J. J., & Morton, J. H. (1953). Cancer as a chronic
disease. JAMA, 152(12), 1144. doi:10.1001/
jama.1953.03690120060018
Naus, M. J., Ishler, M. D., Parrott, C. E., & Kovacs, S. A. (2009).
Cancer survivor adaptation model: Conceptualizing
cancer as a chronic illness. Journal of Clinical
Psychology, 65(12), 1350–1359. doi:10.1002/jclp.20622
Phillips, J. L., & Currow, D. (2010). Cancer as a chronic
disease. Collegian, 17(2), 47–50. doi:10.1016/j.
colegn.2010.04.007
Polinsky, M. L. (1994). Functional status of long-term breast
cancer survivors: Demonstrating chronicity. Health &
Social Work, 19(3), 165–173. doi:10.1093/hsw/19.3.165
Pulte, D., Redaniel, M. T., Bird, J., & Jeffreys, M. (2015).
Survival for patients with chronic leukemias in the US
and Britain: Age-related disparities and changes in
the early 21st century. European Journal of
Haematology, 94(6), 540–545. doi:10.1111/ejh.12468
Reed, E., & Corner, J. (2015). Defining the illness trajectory
of metastatic breast cancer. BMJ Supportive &
Palliative Care, 5(4), 358–365. doi:10.1136/
bmjspcare-2012-000415
Schmidt, H. (2016). Chronic disease prevention and health
promotion. Springer. doi:10.1007/978-3-319-23847-0_5
Pizzoli et al., Cogent Psychology (2019), 6: 1577593
https://doi.org/10.1080/23311908.2019.1577593
Page 15 of 17
Sutton, A. (2016). Redefinition of skin cancer as a chronic
disease. 152(3), 4–5. doi:10.1001/jamaderma-
tol.2015.4215.Conflict
Tritter, J. (April 2002). Cancer as a chronic illness?
Reconsidering categorization and exploring
experience. (2017). doi:10.1046/j.1365-
2354.2002.00345.x
US Department of Health and Human Services. (2010).
Multiple chronic conditions - a strategic framework:
Optimum health and quality of life for individuals with
multiple chronic conditions. Washington, DC.
Retrieved from https://www.hhs.gov/sites/default/
files/ash/initiatives/mcc/mcc_framework.pdf
Wagner, E. H. (1998). Chronic disease management: What
will it take to improve care for chronic illness?
Effective Clinical Practice : ECP, 1(1), 2–4. Retrieved
from http://www.ncbi.nlm.nih.gov/pubmed/
10345255
Walker, C. (2001). Recognising the changing boundaries
of illness in defining terms of chronic illness:
A prelude to understanding the changing needs of
people with chronic illness. Australian Health Review,
24(2), 207–214. Retrieved from http://ovidsp.ovid.
com/ovidweb.cgi?T=JS&PAGE=reference&D=
med4&NEWS=N&AN=11496465
Ward, B. W., Schiller, J. S., & Goodman, R. A. (2014).
Multiple chronic conditions among US adults:
A 2012 update. Vol. 11, 130389. doi:10.5888/
pcd11.130389
Wellard, S. (1998). Constructions of chronic illness.
International Journal of Nursing Studies, 35, 49–55.
WHO. (2015). Chronic diseases and health promotion.
Retrieved from http://www.who.int/chp/en/
World Health Organization. (2011). Chronic diseases.
http://www.who.int/topics/chronic_diseases/en/
Appendix A.
Table A1. Search strategy for scientific literature
Source Search strategy N hints
Ovid MEDLINE(R) Epub Ahead of
Print, In-Process & Other Non-
Indexed Citations, Ovid
MEDLINE(R) Daily, Ovid MEDLINE
and Versions(R) <1946 to
31 January 2018>
1 (chronic or chronicity).m_titl.
(400695)
2 defin$.m_titl. (64100)
3 1 and 2 (824)
4 limit 3 to cancer (218)
5 exp Chronic Disease/(252703)
6 exp neoplasms/(3117934)
7 5 and 6 (17549)
8 defin$.mp. [mp = title, abstract,
original title, name of substance
word, subject heading word,
floating sub-heading word, keyword
heading word, protocol
supplementary concept word, rare
disease supplementary concept
word, unique identifier, synonyms]
(1165071)
9 7 and 8 (889)
10 neoplasms/(393294)
11 9 and 10 (186)
12 4 or 11 (400)
13 limit 12 to (humans and english)
(337)
14 limit 13 to yr = “1991–2019”
(304)
15 limit 14 to yr = “2018–2019” (7)
304
Embase (((“chronic”:ti OR “chroncity”:ti) AND
(“cancer*”:ab,ti OR “neoplas*”:ab,ti
OR “tumor*”:ab,ti OR “tumour*”:ab,
ti OR “malignan*”:ab,ti OR
“carcino*”:ab,ti) AND “defin*”:ti)
AND [embase]/lim NOT ([embase]/
lim AND [medline]/lim) AND
[english]/lim) AND “human”/de
45
PubMed (((chronic[Title] OR chronicity[Title]))
AND cancer) AND defin*[Title]
130
(Continued)
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Source Search strategy N hints
Scopus ((TITLE (chronic OR chronicity)) AND
(TITLE (defin*)) AND (TITLE-ABS-KEY
(cancer* OR neoplas* OR tumor* OR
tumour* OR malignan* OR
carcino*)))
AND NOT (INDEX (medline))
AND (LIMIT-TO (LANGUAGE,
“English”))
24
ProQuest Psychology (1) ti(chronic OR chronicity) AND
defin*
(2) ti(cancer* OR tumor* OR
tumour* OR malignan* OR
neoplas* OR carcino*)
(3) 1 OR 2
7
Total Hints 510
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